| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8649386 | Cardiovascular Revascularization Medicine | 2018 | 5 Pages |
Abstract
- The incidence of ischemic heart failure has diminished with the adoption of percutaneous coronary intervention.
- The landmark EPHESUS study established eplerenone in the management of patients with acute myocardial infarction and a left ventricular ejection fraction <40%.
- The applicability of EPHESUS and therefore eplerenone in the current era of interventional cardiology is controversial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Jonathan Hinton, Michael Mahmoudi, Aung Myat, Nick Curzen,